Literature DB >> 31916079

A contiguous microdeletion syndrome at Xp23.13 with non-obstructive azoospermia and congenital cataracts.

Aubrey Milunsky1,2, Jeff M Milunsky3,4, Weilai Dong5, Hayk Hovhannisyan3, Robert D Oates6.   

Abstract

Non-obstructive azoospermia accounts for 10-15% of male infertility, resulting in 60% of all cases of azoospermia and affecting about 1% of the male population. About 30% of these cases are due to Y chromosome microdeletions, chromosome abnormalities, or hormonal disorders. Pathogenic variants in genes on the sex chromosomes have key roles in spermatogenic failure. The co-occurrence of azoospermia and congenital cataracts ranges between 1 in 165,000 and 1 in 500,000. Our 28-year-old patient with normal intelligence and abnormally shaped teeth presented with both disorders. A microarray revealed a microdeletion at Xp23.13 with a whole NHS gene deletion as well as a contiguous deletion of two other genes [SCML1 and RAI2]. This observation represents the first report of non-obstructive azoospermia with congenital cataracts and a contiguous deletion of the SCML1 gene, a transcript of which is exclusively expressed in the testis. SCML1 is the putative culprit gene, which requires functional study or animal experiments. Our analysis of 60 known spermatogenesis failure-related genes by whole-exome sequencing revealed no other candidate. The Nance-Horan syndrome due to pathogenic variants in the NHS gene at Xp23.13 including whole gene deletion does not have azoospermia as a feature. Our report adds to the completeness of genetic counseling for an individual with azoospermia and congenital cataracts.

Entities:  

Keywords:  Azoospermia; Congenital cataracts; Microdeletion; SCML1 gene; Spermatogenesis

Mesh:

Year:  2020        PMID: 31916079      PMCID: PMC7056753          DOI: 10.1007/s10815-019-01685-6

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  25 in total

1.  A multitude of genes expressed solely in meiotic or postmeiotic spermatogenic cells offers a myriad of contraceptive targets.

Authors:  Nikolaus Schultz; F Kent Hamra; David L Garbers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-02       Impact factor: 11.205

2.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

3.  Incidence and Characteristics of Congenital Cataract Surgery in France from 2010 to 2012: The EPISAFE Program.

Authors:  Vincent Daien; Annick Le Pape; Didier Heve; Max Villain; Dominique Bremond Gignac
Journal:  Ophthalmic Res       Date:  2017-06-20       Impact factor: 2.892

4.  From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline.

Authors:  Geraldine A Van der Auwera; Mauricio O Carneiro; Christopher Hartl; Ryan Poplin; Guillermo Del Angel; Ami Levy-Moonshine; Tadeusz Jordan; Khalid Shakir; David Roazen; Joel Thibault; Eric Banks; Kiran V Garimella; David Altshuler; Stacey Gabriel; Mark A DePristo
Journal:  Curr Protoc Bioinformatics       Date:  2013

5.  A novel Xp22.13 microdeletion in Nance-Horan syndrome.

Authors:  Andrea Accogli; Monica Traverso; Francesca Madia; Tommaso Bellini; Maria Stella Vari; Francesca Pinto; Valeria Capra
Journal:  Birth Defects Res       Date:  2017-05-02       Impact factor: 2.344

6.  Identification of a microdeletion at Xp22.13 in a Taiwanese family presenting with Nance-Horan syndrome.

Authors:  Hsiao-Mei Liao; Dau-Ming Niu; Yan-Jang Chen; Jye-Siung Fang; Shih-Jen Chen; Chia-Hsiang Chen
Journal:  J Hum Genet       Date:  2010-09-30       Impact factor: 3.172

7.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

8.  Identification of the gene for Nance-Horan syndrome (NHS).

Authors:  S P Brooks; N D Ebenezer; S Poopalasundaram; O J Lehmann; A T Moore; A J Hardcastle
Journal:  J Med Genet       Date:  2004-10       Impact factor: 6.318

Review 9.  Mutations and mechanisms in congenital and age-related cataracts.

Authors:  Alan Shiels; J Fielding Hejtmancik
Journal:  Exp Eye Res       Date:  2016-06-19       Impact factor: 3.467

10.  Whole exome sequencing identified a novel truncation mutation in the NHS gene associated with Nance-Horan syndrome.

Authors:  Chao Ling; Ruifang Sui; Fengxia Yao; Zhihong Wu; Xue Zhang; Shuyang Zhang
Journal:  BMC Med Genet       Date:  2019-01-14       Impact factor: 2.103

View more
  3 in total

1.  Large-scale analyses of the X chromosome in 2,354 infertile men discover recurrently affected genes associated with spermatogenic failure.

Authors:  Antoni Riera-Escamilla; Matthias Vockel; Liina Nagirnaja; Miguel J Xavier; Albert Carbonell; Daniel Moreno-Mendoza; Marc Pybus; Ginevra Farnetani; Viktoria Rosta; Francesca Cioppi; Corinna Friedrich; Manon S Oud; Godfried W van der Heijden; Armin Soave; Thorsten Diemer; Elisabet Ars; Josvany Sánchez-Curbelo; Sabine Kliesch; Moira K O'Bryan; Eduard Ruiz-Castañe; Fernando Azorín; Joris A Veltman; Kenneth I Aston; Donald F Conrad; Frank Tüttelmann; Csilla Krausz
Journal:  Am J Hum Genet       Date:  2022-07-08       Impact factor: 11.043

2.  A novel Nance-Horan syndrome mutation identified by next-generation sequencing in a Chinese family.

Authors:  Hong-Yan Sun; Hong-Jing Zhu; Ru-Xu Sun; Ying Wang; Jia-Nan Wang; Bing Qin; Wei-Wei Zhang; Jiang-Dong Ji
Journal:  Int J Ophthalmol       Date:  2022-06-18       Impact factor: 1.645

3.  Fine Breakpoint Mapping by Genome Sequencing Reveals the First Large X Inversion Disrupting the NHS Gene in a Patient with Syndromic Cataracts.

Authors:  Alejandra Damián; Raluca Oancea Ionescu; Marta Rodríguez de Alba; Alejandra Tamayo; María José Trujillo-Tiebas; María Carmen Cotarelo-Pérez; Olga Pérez Rodríguez; Cristina Villaverde; Lorena de la Fuente; Raquel Romero; Gonzalo Núñez-Moreno; Pablo Mínguez; Carmen Ayuso; Marta Cortón
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.